Vivos Therapeutics, Inc. Common Stock

VVOSNASDAQUSD
0.86 USD
0.17 (24.84%)AT CLOSE (11:59 AM EDT)
0.81
0.06 (6.42%)
POST MARKET (AS OF 04:33 PM EDT)
Post Market
AS OF 04:33 PM EDT
0.81
0.06 (6.42%)
🟢Market: OPEN
Open?$0.73
High?$1.36
Low?$0.70
Prev. Close?$0.69
Volume?67.6M
Avg. Volume?172.7K
VWAP?$1.07
Rel. Volume?391.76x
Bid / Ask
Bid?$0.73 × 100
Ask?$0.98 × 100
Spread?$0.25
Midpoint?$0.86
Valuation & Ratios
Market Cap?9.6M
Shares Out?13.9M
Float?10.7M
Float %?78.8%
P/E Ratio?N/A
P/B Ratio?-8.42
EPS?-$1.80
Dividend?0.00%
Ex-Dividend?N/A

Vivos Therapeutics, Inc. Common Stock (VVOS) is currently trading at $0.81. VVOS shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (2195.9%) and a bearish Death Cross on the long-term moving averages. On the valuation side, VVOS appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Employees
268
Market Cap
8.9M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2020-12-11
Address
7921 SOUTHPARK PLAZA,
LITTLETON, CO 80120
Phone: (866)908-4867
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
80
Short Sent.?
44
Piotroski F-Score?2/9Weak
Altman Z-Score?-10.04Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?9.12%Elevated
Short Interest?978.1K
Days to Cover?6.4
Free Float10.7M
Avg Daily Volume151.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?0.27Weak
Quick Ratio?0.27Weak
Cash Ratio?0.12Low
Debt/Equity?-6.92Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
S&P
97
-8.42CHEAP
P/S?
Peers
100
S&P
97
0.49CHEAP
P/FCF?
N/A
EV/EBITDA?
S&P
97
-0.7CHEAP
EV/Sales?
Peers
100
S&P
94
0.78CHEAP
Returns & Efficiency
ROE?
Peers
50
S&P
97
2,195.9%STRONG
ROA?
S&P
3
-99.8%WEAK
Cash Flow & Enterprise
FCF?$-19714000
Enterprise Value?$15.3M
Fundamentals ratios updated end of day